Pan F. Chan

3.7k total citations
42 papers, 2.1k citations indexed

About

Pan F. Chan is a scholar working on Molecular Biology, Surgery and Infectious Diseases. According to data from OpenAlex, Pan F. Chan has authored 42 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 10 papers in Surgery and 7 papers in Infectious Diseases. Recurrent topics in Pan F. Chan's work include Cancer therapeutics and mechanisms (12 papers), Bioactive Compounds and Antitumor Agents (6 papers) and Antimicrobial Resistance in Staphylococcus (6 papers). Pan F. Chan is often cited by papers focused on Cancer therapeutics and mechanisms (12 papers), Bioactive Compounds and Antitumor Agents (6 papers) and Antimicrobial Resistance in Staphylococcus (6 papers). Pan F. Chan collaborates with scholars based in United Kingdom, United States and Canada. Pan F. Chan's co-authors include Simon J. Foster, B.D. Bax, Mark O. Clements, Eileen Ingham, Neil Osheroff, Jianzhong Huang, Andrew Fosberry, Anthony Shillings, Michael N. Gwynn and Paul Homes and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nature Communications.

In The Last Decade

Pan F. Chan

42 papers receiving 2.1k citations

Peers

Countries citing papers authored by Pan F. Chan

Since Specialization

Citations

This map shows the geographic impact of Pan F. Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pan F. Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pan F. Chan more than expected).

Fields of papers citing papers by Pan F. Chan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pan F. Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pan F. Chan. The network helps show where Pan F. Chan may publish in the future.

Co-authorship network of co-authors of Pan F. Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Pan F. Chan. A scholar is included among the top collaborators of Pan F. Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pan F. Chan. Pan F. Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mechanism of Action of Gepotidacin: Well-Balanced Dual-Targeting against Neisseria gonorrhoeae Gyrase and Topoisomerase IV in Cells and In Vitro 2025 ·ACS Infectious Diseases ·(unknown), (unknown), (unknown), Jianzhong Huang, (unknown), Pan F. Chan, Neil Osheroff	2
2	Crystallization and initial crystallographic analysis of covalent DNA-cleavage complexes of Staphyloccocus aureus DNA gyrase with QPT-1, moxifloxacin and etoposide 2015 ·Acta Crystallographica Section F Structural Biology Communications ·Srikannathasan Velupillai, Alexandre Wohlkönig, Anthony Shillings, Onkar Singh, Pan F. Chan, Jianzhong Huang, Michael N. Gwynn, Andrew Fosberry, Paul Homes, Martin Hibbs, (unknown), Claus Spitzfaden, B.D. Bax	16
3	Structural basis of DNA gyrase inhibition by antibacterial QPT-1, anticancer drug etoposide and moxifloxacin 2015 ·Nature Communications ·Pan F. Chan, Srikannathasan Velupillai, Jianzhong Huang, Haifeng Cui, Andrew Fosberry, Minghua Gu, Michael M. Hann, Martin Hibbs, Paul Homes, Karen Ingraham, (unknown), (unknown), Anthony Shillings, Claus Spitzfaden, Robert D. Tanner, (unknown), Robert A. Stavenger, B.D. Bax, Michael N. Gwynn	122
4	High-yield production and characterization of biologically active GST-tagged human topoisomerase IIα protein in insect cells for the development of a high-throughput assay 2010 ·Protein Expression and Purification ·Praveen Kumar Singh, Pan F. Chan, Martin Hibbs, (unknown), (unknown), Daniel A. Thomas, (unknown), Kathleen T. Gallagher, Namir J. Hassan	13
5	Newspaper reporting of meticillin-resistant Staphylococcus aureus and ‘the dirty hospital’ 2010 ·Journal of Hospital Infection ·Pan F. Chan, (unknown), (unknown), Jackie Harrison	18
6	Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance. Nat Struct Mol Biol 17(9): 1152-1153 2010 ·Alexandre Wohlkönig, Pan F. Chan, Andrew Fosberry, Paul Homes, Jianzhong Huang, Michael Kranz, (unknown), Timothy J. Miles, Neil D. Pearson, Rajika L. Perera, Anthony Shillings, Michael N. Gwynn, B.D. Bax	22
7	VEGF and VEGF Receptor Expression in Human Chronic Critical Limb Ischaemia 2004 ·European Journal of Vascular and Endovascular Surgery ·Sohail Choksy, A. Graham Pockley, (unknown), Pan F. Chan	22
8	Novel Antibacterials: A Genomics Approach to Drug Discovery 2002 ·PubMed ·Pan F. Chan, Ricardo Macarrón, David Payne, Magdalena Zalacaín, David Holmes	29
9	accessory regulators: expression within biofilms and effect on adhesion 2001 ·Microbes and Infection ·Jonathan Pratten, Simon J. Foster, Pan F. Chan, Michael Wilson, Sean P. Nair	50
10	Aortoiliac Stenting, Determinants of Clinical Outcome 1999 ·European Journal of Vascular and Endovascular Surgery ·Shah Nawaz, Trevor Cleveland, P.A. Gaines, Jonathan Beard, Pan F. Chan	26
11	The effect of radiographic contrast media on human vascular smooth muscle cells. 1998 ·British Journal of Radiology ·Yì Wáng, Pan F. Chan, Sameh K. Morcos	8
12	Photodynamic therapy in a cell culture model of human intimal hyperplasia 1995 ·European Journal of Vascular and Endovascular Surgery ·Mohammed S. Sobeh, Pan F. Chan, (unknown), Alan J. Wood, F W Cross	4
13	Inhibition of human vascular smooth muscle cell proliferation by lovastatin: the role of isoprenoid intermediates of cholesterol synthesis 1994 ·European Journal of Clinical Investigation ·(unknown), M. Patel, Pan F. Chan, (unknown), Gerard F. Clunn, Karen Gallagher, Alun D. Hughes, Michael Schächter, John H. Wolfe, Peter S. Sever	76
14	Venous reflux in patients with previous deep venous thrombosis: Correlation with ulceration and other symptoms 1994 ·Journal of Vascular Surgery ·Nicos Labropoulos, M. Leon, Andrew Nicolaides, (unknown), N. Volteas, Fernando Ortega, Pan F. Chan	79
15	Cell biology of human vascular smooth muscle. 1994 ·PubMed ·Pan F. Chan	9
16	Abnormal growth regulation of vascular smooth muscle cells by heparin in patients with restenosis 1993 ·The Lancet ·Pan F. Chan, Mahendra K. Patel, (unknown), (unknown), Michael Schächter, Peter S. Sever, (unknown), John H. Wolfe	49
17	A novel strategy for the isolation of luxl homologues: evidence for the widespread distribution of a LuxR:Luxl superfamily in enteric bacteria 1993 ·Molecular Microbiology ·Simon Swift, Michael K. Winson, Pan F. Chan, Nigel J. Bainton, (unknown), Philip J. Reeves, Catherine Rees, Siri Ram Chhabra, Philip J. Hill, John Throup, Barrie W. Bycroft, George P. C. Salmond, Paul Williams, Gordon S.A.B. Stewart	169
18	Cellular biology of human intimal hyperplastic stenosis 1993 ·European Journal of Vascular Surgery ·Pan F. Chan, (unknown), M. Patel, (unknown), Michael Schächter, Peter S. Sever, John H. Wolfe	31
19	Detection of superior mesenteric and coeliac artery stenosis with colour flow Duplex imaging 1993 ·European Journal of Vascular Surgery ·N. Volteas, Nicos Labropoulos, M. Leon, Evi Kalodiki, Pan F. Chan, Andrew Nicolaides	14
20	Popliteal vein entrapment in the normal population 1992 ·European Journal of Vascular Surgery ·M. Leon, N. Volteas, Nicos Labropoulos, (unknown), Evi Kalodiki, Charles Fisher, Pan F. Chan, Gianni Belcaro, Andrew Nicolaides	50

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact